Personalized medical care
because you're unique
Cancer Care Ontario Features ArcticDxs Colo Risk™ in 'Ontario Cancer Plan'
Toronto, Ontario, March 20, 2008 — Cancer Care Ontario (www.cancercare.on.ca) unveils components of its official blueprint for the development of its cancer management program for the next five years. ArcticDx's genetic test, Colo Risk™ is featured. Colo Risk™ is a sputum or a blood test intended to support population screening for Colorectal Cancer. Individuals at high risk for this devastating disease can be identified for regular follow up assessments. Colorectal Cancer can be beaten if detected early. Follow the link for the complete story and video presentation.
www.cancercare.on.ca/english/ocphome/ researchimprove/ARCTIC/
